Topco Scientific Co.,Ltd. (TPE:5434)
Taiwan · Delayed Price · Currency is TWD 321.00
+3.00 (0.94%)
At close: Feb 11, 2026
Topco Scientific Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 63,863 | 54,768 | 46,944 | 50,555 | 41,098 | 35,233 |
Other Revenue | 2,329 | 2,229 | 2,329 | 2,423 | 1,571 | 934.93 |
| 66,192 | 56,997 | 49,273 | 52,978 | 42,669 | 36,168 | |
Revenue Growth (YoY) | 24.13% | 15.68% | -6.99% | 24.16% | 17.97% | 14.09% |
Cost of Revenue | 57,787 | 49,279 | 42,855 | 46,453 | 37,457 | 31,863 |
Gross Profit | 8,405 | 7,718 | 6,419 | 6,525 | 5,212 | 4,305 |
Selling, General & Admin | 4,008 | 3,712 | 3,091 | 3,139 | 2,559 | 2,143 |
Research & Development | 62.03 | 66.64 | 117.48 | 156.41 | 101.17 | 100.23 |
Other Operating Expenses | -1.29 | -4.26 | 12.02 | -0.29 | -0.29 | -0.29 |
Operating Expenses | 4,068 | 3,775 | 3,221 | 3,296 | 2,660 | 2,243 |
Operating Income | 4,337 | 3,943 | 3,198 | 3,230 | 2,552 | 2,062 |
Interest Expense | -95.7 | -113.68 | -99.57 | -53.11 | -34.23 | -27.17 |
Interest & Investment Income | 181.89 | 159.92 | 190.85 | 122.91 | 60.98 | 59.38 |
Earnings From Equity Investments | 542.09 | 609.81 | 471.82 | 541.72 | 422.68 | 373.35 |
Currency Exchange Gain (Loss) | -76.22 | -8.45 | -13.74 | 123.55 | -38.39 | -44.91 |
Other Non Operating Income (Expenses) | 88.7 | 95.35 | 78.86 | 54.96 | 50.18 | 34.93 |
EBT Excluding Unusual Items | 4,977 | 4,686 | 3,826 | 4,020 | 3,013 | 2,457 |
Merger & Restructuring Charges | - | - | - | - | -0.12 | - |
Gain (Loss) on Sale of Investments | 157.39 | 83.76 | 80.15 | 248.5 | 45.27 | 7.6 |
Gain (Loss) on Sale of Assets | -13.98 | -10.25 | -26.11 | -26.65 | -8.53 | 94.55 |
Asset Writedown | -30.4 | -30.4 | - | - | -10.03 | - |
Pretax Income | 5,090 | 4,729 | 3,880 | 4,242 | 3,040 | 2,559 |
Income Tax Expense | 1,199 | 1,064 | 1,028 | 1,167 | 738.89 | 494.1 |
Earnings From Continuing Operations | 3,891 | 3,665 | 2,853 | 3,075 | 2,301 | 2,065 |
Minority Interest in Earnings | -10.34 | -9.16 | -17.89 | -56.7 | -6.5 | 3.03 |
Net Income | 3,881 | 3,656 | 2,835 | 3,018 | 2,294 | 2,068 |
Net Income to Common | 3,881 | 3,656 | 2,835 | 3,018 | 2,294 | 2,068 |
Net Income Growth | 15.30% | 28.96% | -6.08% | 31.55% | 10.93% | 20.09% |
Shares Outstanding (Basic) | 191 | 190 | 185 | 182 | 182 | 182 |
Shares Outstanding (Diluted) | 196 | 195 | 189 | 184 | 183 | 183 |
Shares Change (YoY) | 0.07% | 3.29% | 2.84% | 0.48% | -0.09% | 0.23% |
EPS (Basic) | 20.29 | 19.29 | 15.36 | 16.61 | 12.63 | 11.38 |
EPS (Diluted) | 19.89 | 18.78 | 15.03 | 16.41 | 12.53 | 11.29 |
EPS Growth | 14.95% | 24.93% | -8.39% | 30.97% | 10.98% | 19.85% |
Free Cash Flow | 5,126 | 866.68 | -152.61 | 2,815 | 2,191 | 1,734 |
Free Cash Flow Per Share | 26.22 | 4.44 | -0.81 | 15.30 | 11.97 | 9.46 |
Dividend Per Share | 12.000 | 12.000 | 10.000 | 10.000 | 8.800 | 8.000 |
Dividend Growth | 20.00% | 20.00% | - | 13.64% | 10.00% | 23.08% |
Gross Margin | 12.70% | 13.54% | 13.03% | 12.32% | 12.21% | 11.90% |
Operating Margin | 6.55% | 6.92% | 6.49% | 6.10% | 5.98% | 5.70% |
Profit Margin | 5.86% | 6.41% | 5.75% | 5.70% | 5.38% | 5.72% |
Free Cash Flow Margin | 7.74% | 1.52% | -0.31% | 5.31% | 5.14% | 4.79% |
EBITDA | 4,649 | 4,261 | 3,526 | 3,547 | 2,816 | 2,269 |
EBITDA Margin | 7.02% | 7.48% | 7.16% | 6.69% | 6.60% | 6.28% |
D&A For EBITDA | 312.65 | 318.03 | 327.86 | 316.89 | 263.9 | 207.72 |
EBIT | 4,337 | 3,943 | 3,198 | 3,230 | 2,552 | 2,062 |
EBIT Margin | 6.55% | 6.92% | 6.49% | 6.10% | 5.98% | 5.70% |
Effective Tax Rate | 23.55% | 22.50% | 26.48% | 27.50% | 24.31% | 19.30% |
Revenue as Reported | 66,192 | 56,997 | 49,273 | 52,978 | 42,669 | 36,168 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.